lisofylline has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianco, JA; Bursten, S; Michnick, J; Rice, GC; Rosen, J; Singer, JW; Weeks, R | 1 |
Bursten, SL; Chaney, RB; Guidot, DM; Hybertson, BM; Repine, AJ; Repine, JE; Rice, GC; Singer, JW | 1 |
2 other study(ies) available for lisofylline and interleukin-8
Article | Year |
---|---|
CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo.
Topics: 3T3 Cells; Animals; Cells, Cultured; Dinoprostone; Fibroblasts; Humans; In Vitro Techniques; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Interleukin-8; Mice; Monokines; Pentoxifylline; Phosphatidic Acids; RNA, Messenger; Sialoglycoproteins; Tumor Necrosis Factor-alpha | 1994 |
Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs.
Topics: Animals; Chemotaxis, Leukocyte; Humans; Hydrogen Peroxide; Interleukin-8; Linoleic Acid; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oleic Acid; Organ Size; Oxidative Stress; Pentoxifylline; Perfusion; Phosphatidic Acids; Rats; Rats, Sprague-Dawley; Superoxides | 1997 |